Jenkem Technology Co LtdClarified it has not directly supplied LNP core raw materials to Moderna, potentially reducing expected demand.
YMTC Holdings' application for an initial public offering and listing on the STAR Market has been accepted by the Shanghai Stock Exchange, with a planned fundraising amount of 33 billion yuan. The sponsors are CITIC Securities and China Securities. The prospectus shows that the company's profitability has improved rapidly since turning a profit in 2024. From January to March 2026, it achieved operating revenue of 47.042 billion yuan and net profit attributable to the parent company of 33.379 billion yuan. According to TrendForce data, during the same period, the company ranked third globally and first in China among NAND Flash manufacturers by both sales revenue and shipment volume. In addition, CanSino Biologics announced that it is developing mRNA preventive vaccines and therapeutic biological products. JenKem Technology clarified that it has not directly supplied LNP core raw materials to Moderna. Several other STAR Market companies, including Sinovac Biotech, Hwatsing Technology, and UCloud, disclosed their semi-annual results.
Jenkem Technology Co LtdClarified it has not directly supplied LNP core raw materials to Moderna, potentially reducing expected demand.
Cansino Biologics IncDeveloping mRNA preventive vaccines and therapeutic biological products, but no specific progress or impact details.
Hwatsing Technology Co. Ltd. A
Shandong Kexing Bioproducts Co. Ltd. A
UCloud Technology Co Ltd
Cloudwalk Technology Co. Ltd. A